Why We Invested in Resilient Lifescience — Preventing Opioid Overdose

Excited to announce our investment in Resilient Lifescience, which is taking on the opioid epidemic by developing a wearable system to detect and automatically reverse overdoses. Tau Ventures is an AI-first fund in Silicon Valley investing primarily in seed and we occasionally take earlier or later bets when we see immense promise. We are also investing in US / Canada but in exceptional cases will consider a deal outside. Resilient was founded in 2022 in Pittsburgh and impressed us with (1) a strong need, (2) building an execution-focused team, and (3) their business strategy. 1) The Need The opioid crisis…...